Diarrhoea and Angiotensin II Receptor Blockers: is there any difference between the different drugs?

2021 ◽  
Author(s):  
Julia Guion‐Firmin ◽  
Samuel Tessier ◽  
Jean‐Louis Montastruc
Keyword(s):  
Angiotensin Ii ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Receptor Blockers

The Impact of Angiotensin-II Receptor Blockers on Cardiovascular Events in Hypertensive Patients – Evidence from Real-life Databases

2010 ◽  
Vol 6 (3) ◽  
pp. 33
Author(s):  
Robert J Petrella ◽  
Keyword(s):  
Angiotensin Ii ◽  
Antihypertensive Drugs ◽  
Real Life ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Real World Setting ◽  
Actual Experience ◽  
Receptor Blockers ◽  
Randomised Controlled ◽  
The Impact

It is widely recognised that hypertension is a major risk factor for the development of future cardiovascular (CV) events, which in turn are a major cause of morbidity and mortality. Blood pressure (BP) control with antihypertensive drugs has been shown to reduce the risk of CV events. Angiotensin-II receptor blockers (ARBs) are one such class of antihypertensive drugs and randomised controlled trials (RCTs) have shown ARB-based therapies to have effective BP-lowering properties. However, data obtained under these tightly controlled settings do not necessarily reflect actual experience in clinical practice. Real-life databases may offer alternative information that reflects an uncontrolled real-world setting and complements and expands on the findings of clinical trials. Recent analyses of practice-based real-life databases have shown ARB-based therapies to be associated with better persistence and adherence rates and with superior BP control than non-ARB-based therapies. Analyses of real-life databases also suggest that ARB-based therapies may be associated with a lower risk of CV events than other antihypertensive-drug-based therapies.

scholarly journals Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis

2021 ◽  
pp. ejhpharm-2021-002739
Author(s):  
Sakae Fukushima ◽  
Manami Oishi ◽  
Hiroya Aso ◽  
Kifumi Arai ◽  
Yuuki Sasaki ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Serum Potassium ◽  
Potassium Level ◽  
Serum Potassium Level ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Single Centre ◽  
Receptor Blockers

Effects of angiotensin II receptor blockers on insulin resistance

2010 ◽  
Vol 33 (8) ◽  
pp. 778-778
Author(s):  
Pietro Dario Ragonesi
Keyword(s):  
Insulin Resistance ◽  
Angiotensin Ii ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Receptor Blockers

scholarly journals Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan

2012 ◽  
Vol 15 (1) ◽  
pp. S111-S115 ◽  
Author(s):  
Yen-Ying Lee ◽  
Paul Hsiao ◽  
You-Meei Lin ◽  
Yu-Hsuan Yen ◽  
Hsiang-Yin Chen
Keyword(s):  
Angiotensin Ii ◽  
Medical Center ◽  
Angiotensin Ii Receptor Blockers ◽  
Successful Implementation ◽  
Angiotensin Ii Receptor ◽  
Receptor Blockers ◽  
Therapeutic Interchange
Sign in / Sign up

Export Citation Format

Share Document